摘要
Dear Editor,Myocardial infarction(MI)is one of the leading causes of cardiovascular-related mortality worldwide.Timely restoration of the blood supply to ischemic my-ocardium by thrombolysis or percuta-neous coronary intervention is a com-mon clinical practice and decreases the mortality risk for MI patients(Heusch,2020).
基金
supported by grants from the National Key R&D Program of China(2018YFA0800501,2019YFA0801602)
the National Natural Science Foundation of China(32230032,31730061,31430059,81870198)and Synogen Biopharma Co.,Nanjing,China.
